Citations (35)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Mathieu Zmuda, Kiet Phong Tiev, Juliette Knoeri & Emmanuel Héron. (2013) Successful Use of Infliximab Therapy in Sight-threatening Corticosteroid-resistant Vogt-Koyanagi-Harada Disease. Ocular Immunology and Inflammation 21:4, pages 310-316.
Read now
Read now
Robert M Beardsley, Eric B Suhler, James T Rosenbaum & Phoebe Lin. (2013) Pharmacotherapy of scleritis: current paradigms and future directions. Expert Opinion on Pharmacotherapy 14:4, pages 411-424.
Read now
Read now
Miguel Cordero-Coma, Taygan Yilmaz & Sumru Onal. (2013) Systematic Review of Anti-Tumor Necrosis Factor-alpha Therapy for Treatment of Immune-mediated Uveitis. Ocular Immunology and Inflammation 21:1, pages 19-27.
Read now
Read now
Sonia Attia, Sana Khochtali, Rim Kahloun, Sonia Zaouali & Moncef Khairallah. (2012) Vogt–Koyanagi–Harada disease. Expert Review of Ophthalmology 7:6, pages 565-585.
Read now
Read now
Yousuf M. Khalifa, M. Rami Bailony & Nisha R. Acharya. (2010) Treatment of Pediatric Vogt-Koyanagi-Harada Syndrome with Infliximab. Ocular Immunology and Inflammation 18:3, pages 218-222.
Read now
Read now
Miguel Cuchacovich, Federica Solanes, Gonzalo Díaz, Tomás Cermenati, Samuel Avila, Juan Verdaguer, Juan Ignacio Verdaguer, Cristian Carpentier, Juan Stopel, Basilio Rojas, Leonidas Traipe, Patricia Gallardo, Francisca Sabugo, Mario Zanoli, Guillermo Merino & Francisco Villarroel. (2010) Comparison of the Clinical Efficacy of Two Different Immunosuppressive Regimens in Patients with Chronic Vogt-Koyanagi-Harada Disease. Ocular Immunology and Inflammation 18:3, pages 200-207.
Read now
Read now
Houman D Hemmati & James P Dunn. (2010) Biologic therapy for uveitis. Expert Review of Ophthalmology 5:2, pages 225-239.
Read now
Read now
Articles from other publishers (28)
Najiha Rahman, Jose Carlo M Artiaga, Konstantinos Bouras, Joshua Luis, Angela Rees & Mark Westcott. (2023) Immunosuppressive therapy for Vogt-Koyanagi-Harada disease: a retrospective study and review of literature. Journal of Ophthalmic Inflammation and Infection 13:1.
Crossref
Crossref
Ioannis Papasavvas, Ilknur Tugal-Tutkun & Carl P. HerbortJr.Jr.. (2022) Mechanisms, Pathophysiology and Current Immunomodulatory/Immunosuppressive Therapy of Non-Infectious and/or Immune-Mediated Choroiditis. Pharmaceuticals 15:4, pages 398.
Crossref
Crossref
Carl P. HerbortJrJr, Ilknur Tugal-Tutkun, Ahmed Abu-El-Asrar, Amod Gupta, Masaru Takeuchi, Christine Fardeau, Alireza Hedayatfar, Cristhian Urzua & Ioannis Papasavvas. (2021) Precise, simplified diagnostic criteria and optimised management of initial-onset Vogt–Koyanagi–Harada disease: an updated review. Eye 36:1, pages 29-43.
Crossref
Crossref
Youning Zhang, Brian C. Toy & Narsing A. Rao. 2022. Albert and Jakobiec's Principles and Practice of Ophthalmology. Albert and Jakobiec's Principles and Practice of Ophthalmology
4339
4354
.
Fabian Vega-Tapia, Mario Bustamante, Rodrigo A. Valenzuela, Cristhian A. Urzua & Loreto Cuitino. (2021) miRNA Landscape in Pathogenesis and Treatment of Vogt–Koyanagi–Harada Disease. Frontiers in Cell and Developmental Biology 9.
Crossref
Crossref
Shizhao Yang, Zhaohao Huang, Xiuxing Liu, He Li, Lihui Xie, Xiaoqing Chen, Feng Wen, Dan Liang & Wenru Su. (2021) Comparative study of adalimumab versus conventional therapy in sight-threatening refractory Behçet’s uveitis with vasculitis. International Immunopharmacology 93, pages 107430.
Crossref
Crossref
Carl P. HerbortJr.Jr., Ilknur Tugal-Tutkun, Moncef Khairallah, Ahmed M. Abu el Asrar, Carlos E. Pavésio & Masoud Soheilian. (2020) Vogt–Koyanagi–Harada disease: recurrence rates after initial-onset disease differ according to treatment modality and geographic area. International Ophthalmology 40:9, pages 2423-2433.
Crossref
Crossref
Akshay S. Thomas. 2020. Uveitis. Uveitis
43
99
.
Youning Zhang, Brian C. Toy & Narsing A. Rao. 2020. Albert and Jakobiec's Principles and Practice of Ophthalmology. Albert and Jakobiec's Principles and Practice of Ophthalmology
1
17
.
Laura Girasoli, Diego Cazzador, Roberto Padoan, Ennio Nardello, Mara Felicetti, Elisabetta Zanoletti, Franco Schiavon & Roberto Bovo. (2018) Update on Vertigo in Autoimmune Disorders, from Diagnosis to Treatment. Journal of Immunology Research 2018, pages 1-16.
Crossref
Crossref
Carl P. Herbort Jr, Ahmed M. Abu El Asrar, Joyce H. Yamamoto, Carlos E. Pavésio, Vishali Gupta, Moncef Khairallah, Ilknur Tugal-Tutkun, Masoud Soheilian, Masuru Takeuchi & Marina Papadia. (2016) Reappraisal of the management of Vogt–Koyanagi–Harada disease: sunset glow fundus is no more a fatality. International Ophthalmology 37:6, pages 1383-1395.
Crossref
Crossref
Radgonde Amer, Hilal Nalcı & Nilüfer Yalçındağ. (2017) Exudative retinal detachment. Survey of Ophthalmology 62:6, pages 723-769.
Crossref
Crossref
Qiaoli Gu, Huilin Yang & Qin Shi. (2017) Macrophages and bone inflammation. Journal of Orthopaedic Translation 10, pages 86-93.
Crossref
Crossref
Ghazala A. Datoo O'Keefe & Narsing A. Rao. (2017) Vogt-Koyanagi-Harada disease. Survey of Ophthalmology 62:1, pages 1-25.
Crossref
Crossref
Marcelo Mendes Lavezzo, Viviane Mayumi Sakata, Celso Morita, Ever Ernesto Caso Rodriguez, Smairah Frutuoso Abdallah, Felipe T. G. da Silva, Carlos Eduardo Hirata & Joyce Hisae Yamamoto. (2016) Vogt-Koyanagi-Harada disease: review of a rare autoimmune disease targeting antigens of melanocytes. Orphanet Journal of Rare Diseases 11:1.
Crossref
Crossref
Sukhum Silpa-archa, Narumol Silpa-archa, Janine M. Preble & C. Stephen Foster. (2016) Vogt–Koyanagi–Harada syndrome: Perspectives for immunogenetics, multimodal imaging, and therapeutic options. Autoimmunity Reviews 15:8, pages 809-819.
Crossref
Crossref
Grace Levy-Clarke, Douglas A. Jabs, Russell W. Read, James T. Rosenbaum, Albert Vitale & Russell N. Van Gelder. (2014) Expert Panel Recommendations for the Use of Anti–Tumor Necrosis Factor Biologic Agents in Patients with Ocular Inflammatory Disorders. Ophthalmology 121:3, pages 785-796.e3.
Crossref
Crossref
Daniel Sánchez-Cano, José Luis Callejas-Rubio, Ricardo Ruiz-Villaverde, Raquel Ríos-Fernández & Norberto Ortego-Centeno. (2013) Off-Label Uses of Anti-TNF Therapy in Three Frequent Disorders: Behçet’s Disease, Sarcoidosis, and Noninfectious Uveitis. Mediators of Inflammation 2013, pages 1-10.
Crossref
Crossref
Hiroshi Goto, P. Kumar Rao & Narsing A. Rao. 2013. Retina. Retina
1326
1336
.
Yuko Kawazoe, Sunao Sugita, Yukiko Yamada, Ai Akino, Keiko Miura & Manabu Mochizuki. (2012) Psoriasis triggered by infliximab in a patient with Behçet’s disease. Japanese Journal of Ophthalmology 57:1, pages 95-97.
Crossref
Crossref
Maria de Lourdes Arellanes-García, Luz Elena Concha-del-Río, Maria del Carmen Preciado-Delgadillo & Claudia Recillas-Gipsert. 2013. Retinal and Choroidal Manifestations of Selected Systemic Diseases. Retinal and Choroidal Manifestations of Selected Systemic Diseases
353
376
.
Anne Riveros Frutos, Pau Romera Romero, Susana Holgado Pérez, José Ramón Anglada Escalona, Melania Martínez-Morillo & Beatriz Tejera Segura. (2012) Enfermedad de Vogt-Koyanagi-Harada. Seminarios de la Fundación Española de Reumatología 13:4, pages 142-146.
Crossref
Crossref
Miguel Cordero. 2012. Tratamiento de la uveítis con fármacos anti-TNF-alfa. Tratamiento de la uveítis con fármacos anti-TNF-alfa
55
59
.
Carlos Jaime Velásquez Franco, Patricia Monsalve, Gloria Isabel Salazar Martínez, Ana Rivera, Liliana Zuluaga, Claudia Durán, Francisco Vargas, Aura Ligia Zapata-Castellanos & Oscar Jaír-Felipe Díaz. (2011) Uveítis y terapia anti-TNF. Revista Colombiana de Reumatología 18:1, pages 42-54.
Crossref
Crossref
Huili LiMasahiko YonedaMasayuki TakeyamaIichiro SugitaHinako TsunekawaHiroshi YamadaDaisuke WatanabeTomoyuki MukaiMasahiro YamamuraMasayoshi IwakiMasahiro Zako. (2010) Effect of Infliximab on Tumor Necrosis Factor-Alpha-Induced Alterations in Retinal Microvascular Endothelial Cells and Retinal Pigment Epithelial Cells. Journal of Ocular Pharmacology and Therapeutics 26:6, pages 549-556.
Crossref
Crossref
Marcela F Bordaberry. (2010) Vogt–Koyanagi–Harada disease: diagnosis and treatments update. Current Opinion in Ophthalmology 21:6, pages 430-435.
Crossref
Crossref
Mohsen Farvardin, Mehrdad Afarid, Morsal Mehryar & Hamid Hosseini. (2010) INTRAVITREAL INFLIXIMAB FOR THE TREATMENT OF SIGHT-THREATENING CHRONIC NONINFECTIOUS UVEITIS. Retina 30:9, pages 1530-1535.
Crossref
Crossref
Gema de la Poza G?mez, Antonio L?pez-San Rom?n, Jaime Masjuan Vallejo, Gemma Arranz de la Mata, Teresa Angueira Lape?a & Daniel Boixeda de Miquel. (2009) Colitis ulcerosa asociada a enfermedad de Vogt-Koyanagi-Harada. Gastroenterolog?a y Hepatolog?a 32:5, pages 343-345.
Crossref
Crossref